By: IPP Bureau
Last updated : June 10, 2023 11:08 am
The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
Asence Pharma, a subsidiary of Ambalal Sarabhai Enterprises Limited, has commenced its new oncology and synthetic API plant at Ranoli, Vadodara.
The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement.
Asence Pharma specializes in the supply of quality pharmaceutical preparations (Bulk Drugs and Formulations) to domestic and international markets. Asence through its operations in India and USA, markets and distributes pharmaceutical preparations worldwide and has more than 100 registered products internationally with an impressive pipeline and capability for development of new medicines.